Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01484938 · ClinicalTrials.gov registry record · NA

Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers

A NA study, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
175
Enrollment target

NCT01484938: Completed NA study, sponsored by Alcon Research.

NCT01484938 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 175 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01484938, a NA study, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target

Study Summary

The purpose of this study was to describe mean differences in corneal staining (type and area) for OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS) at Day 30 compared to Baseline (Day 0).

Primary Outcome

Percentage corneal staining was assessed by the investigator for each of five regions of the cornea; i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Percentage corneal staining was recorded in increments of ten, and the percentages of the five regions were averaged together.

Interventions

  • DEVICE OPTI-FREE PureMoist

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2011-02
Est. Completion 2011-05
Phase NA
Alcon Research

275 total trials

What the finished NCT01484938 record still lists

NCT01484938 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which OPTI-FREE PureMoist is the first listed.

NCT01484938 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01484938 about?

NCT01484938 is a clinical study titled "Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers". The purpose of this study was to describe mean differences in corneal staining (type and area) for OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS) at Day 30 compared to Baseline (Day 0).

What is the current status of trial NCT01484938?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2011-02. Estimated completion is 2011-05.

What interventions are being tested in trial NCT01484938?

The interventions under investigation include: OPTI-FREE PureMoist (DEVICE).

Who is sponsoring clinical trial NCT01484938?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01484938's enrollment target sits among peer trials

175 610th of 2000 higher than 1,391 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01484938, the US trial registry maintained by the National Library of Medicine. NCT01484938 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.